(Q39124984)

9 September 2017

title

A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells (English)

1 reference

9 September 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

Riki Toita

1

1 reference

9 September 2017

Masaharu Murata

2

1 reference

9 September 2017

Kana Abe

3

1 reference

9 September 2017

Sayoko Narahara

4

1 reference

9 September 2017

Jing Shu Piao

5

1 reference

9 September 2017

Jeong-Hun Kang

6

1 reference

9 September 2017

Makoto Hashizume

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

9 September 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Chemical Communications

1 reference

9 September 2017

volume

49

1 reference

9 September 2017

issue

67

1 reference

9 September 2017

page(s)

7442-7444

1 reference

Stealth® liposomes: from theory to product

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Acid-degradable polymers for drug delivery: a decade of innovation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Gene carrier showing all-or-none response to cancer cell signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Impact of albumin on drug delivery--new applications on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Virus-based nanocarriers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

A novel protease activity assay using a protease-responsive chaperone protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Molecular design of protein-based nanocapsules for stimulus-responsive characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Crystal structure of a small heat-shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Photosensitizer efficiency in genetically modified protein cage architectures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Development of human hepatocellular carcinoma cell-targeted protein cages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC44508A

21 January 2018

Identifiers

DOI

10.1039/C3CC44508A

1 reference

9 September 2017

1 reference